# US 5,770,434 A · Soluble peptides having constrained, secondary conformation in solution and method of making same > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 5,770,434 A - Document ID: US5770434A - Status: Granted - Kind: A - Application number: 08/440,787 - Filed: 1995-05-15 - Granted: 1998-06-23 - Earliest claimed: 1990-09-28 - Assignees: Ixsys, Inc. - Inventors: William D. Huse - Web page: https://patentgrep.com/patent/US5770434A ## CPC - C40B 40/02: Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors - C07K 14/005: from viruses - C12N 15/1037: {Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display} - C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease - C07K 2319/00: Fusion polypeptide - C12N 2795/14122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes - C12N 2795/14143: viral genome or elements thereof as genetic vector - C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60) - C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00) - C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00) ## Abstract A method of synthesizing isolated, soluble peptides having constrained secondary structure in solution is described herein. The peptides are encoded by expressible oligonucleotides having a desirable bias of random codon sequences. ## Claims ### Claim 1 A composition of matter comprising a plurality of E. coli cells containing a diverse population of expressible oligonucleotides, each of said oligonucleotides encoding a peptide having a desirable bias of predetermined covalent constraints, wherein each of said oligonucleotides is operationally linked to (i) expression elements, (ii) a suppressible stop codon and (iii) a nucleic acid encoding a coat protein contained within an E. coli filamentous bacteriophage vector so as to be expressed as a fusion protein with said coat protein of said E. coli filamentous bacteriophage in a suppressor host or as a secreted peptide in a non-suppressor host, said expressible oligonucleotides having a desirable bias of random codon sequences and wherein said plurality of E. coli cells comprise at least one of said expressible oligonucleotides which encodes a peptide with constrained secondary structure. ### Claim 2 (depends on 1) The composition of claim 1, wherein said oligonucleotides have more than one codon encoding an amino acid capable of forming a covalent bond. ### Claim 3 (depends on 1) The composition of claim 1, wherein said expressible oligonucleotides are expressed as gVIII-fusion proteins on the surface of and E. coli filamentous bacteriophage. ### Claim 4 (depends on 2) The composition of claim 2, wherein said amino acid is an amino acid selected from the group consisting of cysteine, glutamic acid, lysine, leucine and tyrosine. ### Claim 5 A composition of matter comprising a plurality of E. coli cells containing a diverse population of expressible oligonucleotides, each of said oligonucleotides encoding a peptide having a desirable bias of predetermined covalent constraints, wherein each of said oligonucleotides is operationally linked to expression elements and to a nucleic acid encoding a coat protein contained within an E. coli filamentous bacteriophage vector so as to be expressed as a fusion protein or as a secreted peptide, said expressible oligonucleotides having a desirable bias of random codon sequences produced from random combinations of first and second oligonucleotide precursor populations, each or either of said first and second oligonucleotide precursor populations having a desirable bias of random codon sequences and wherein said plurality of cells comprise at least one of said expressible oligonucleotides which encodes a peptide with constrained secondary structure. ### Claim 6 (depends on 5) The composition of claim 5, wherein said first or second oligonucleotide precursor populations are biased. ### Claim 7 (depends on 5) The composition of claim 5, wherein said first and second oligonucleotide precursor populations are biased. ### Claim 8 (depends on 5) The composition of claim 5, wherein said first or second oligonucleotide precursor populations have more than one codon encoding an amino acid capable of forming a covalent bond. ### Claim 9 (depends on 5) The composition of claim 5, wherein said first and second oligonucleotide precursor populations have at least one codon encoding an amino acid capable of forming a covalent bond. ### Claim 10 (depends on 5) The composition of claim 5, wherein said expressible oligonucleotides are expressed as gVIII-fusion proteins on the surface of an E. coli filamentous bacteriophage. ### Claim 11 (depends on 8, 9) The composition of claim 8 or 9, wherein said amino acid is an amino acid selected from the group consisting of cysteine, glutamic acid, lysine, leucine and tyrosine. ### Claim 12 A kit for the preparation of vectors for the expression of a peptide:coat protein fusion protein or a secreted peptide from a diverse population of random peptides having a desirable bias of predetermined covalent constraints, wherein at least one of said random peptides in said diverse population is a peptide with constrained secondary structure, said peptides being generated from combined first and second oligonucleotide precursor populations which when combined have a desirable bias of random codon sequences, comprising: two E. coli filamentous bacteriophage vectors, a first filamentous bacteriophage vector having a cloning site for said first precursor oligonucleotides and a pair of restriction sites for operationally combining first precursor oligonucleotides with second precursor oligonucleotides; and a second filamentous bacteriophage vector having a cloning site for said second precursor oligonucleotides and a pair of restriction sites complementary to those on said first vector, one or both vectors containing expression elements capable of being operationally linked to said combined first and second precursor oligonucleotides and to a nucleic acid encoding a coat protein. ### Claim 13 (depends on 12) The kit of claim 12, wherein said filamentous bacteriophage vectors are derived from M13, f1 or fd. ### Claim 14 (depends on 12) The kit of claim 12, wherein said first or second oligonucleotide precursor populations are biased toward a pre-determined sequence. ### Claim 15 (depends on 12) The kit of claim 12, wherein said first and second oligonucleotide precursor populations are biased toward a predetermined sequence. ### Claim 16 (depends on 12) The kit of claim 12, wherein said first or second oligonucleotide precursor populations have more than one codon encoding an amino acid capable of forming a covalent bond. ### Claim 17 (depends on 12) The kit of claim 12, wherein said first and second oligonucleotide precursor populations have at least one codon encoding an amino acid capable of forming a covalent bond. ### Claim 18 (depends on 16, 17) The kit of claim 16 or 17, wherein said amino acid is an amino acid selected from the group consisting of cysteine, glutamic acid, lysine, leucine and tyrosine. ### Claim 19 A cloning system for expressing as a peptide:coat protein fusion protein or as a secreted peptide a diverse population of oligonucleotides encoding random peptides having a desirable bias of predetermined covalent constraints, wherein at least one of said oligonucleotides within said diverse population encodes a peptide with constrained secondary structure, said oligonucleotides being generated from a desirable bias of random codon sequences, said cloning system comprising an E. coli filamentous bacteriophage vector having a pair of restriction sites so as to allow the operational combination of said oligonucleotides into a contiguous oligonucleotide encoding said peptide having constrained secondary structure, said contiguous oligonucleotide being operationally linked to expression elements and to a nucleic acid encoding a coat protein contained within an E. coli filamentous bacteriophage so as to be expressed as a peptide:coat protein fusion protein or as a secreted peptide. ### Claim 20 (depends on 19) The cloning system of claim 19, wherein said oligonucleotides have more than one codon encoding an amino acid capable of forming a covalent bond. ### Claim 21 A cloning system for expressing as a peptide:coat protein fusion protein or as a secreted peptide a diverse population of oligonucleotides encoding random peptides having a desirable bias of predetermined covalent constraints wherein at least one of said oligonucleotides within said diverse population encodes a peptide with constrained secondary structure, said oligonucleotides being generated from diverse populations of combined first and second oligonucleotide precursor populations each or either having a desirable bias of random codon sequences said cloning system, comprising: a set of first filamentous bacteriophage vectors having a diverse population of first precursor oligonucleotides having a desirable bias of random codon sequences and a second set of filamentous bacteriophage vectors having a diverse population of second precursor oligonucleotides having a desirable bias of random codon sequences, said first and second vectors each having a pair of restriction sites so as to allow the operational combination of said oligonucleotides into a contiguous oligonucleotide encoding said peptide having constrained secondary structure and to a nucleic acid encoding a bacteriophage coat protein. ### Claim 22 (depends on 21) The composition of claim 21, wherein said first or second oligonucleotide precursor populations are biased. ### Claim 23 (depends on 21) The composition of claim 21, wherein said first and second oligonucleotide precursor populations are biased. ### Claim 24 (depends on 21) The cloning system of claim 21, wherein said first or second oligonucleotide precursor populations have more than one codon encoding an amino acid capable of forming a covalent bond. ### Claim 25 (depends on 21) The cloning system of claim 21, wherein said first and second oligonucleotide precursor populations have at least one codon encoding an amino acid capable of forming a covalent bond. ### Claim 26 (depends on 21) The cloning system of claim 21, wherein said first and second vectors are combined through a pair of restriction sites. ### Claim 27 (depends on 21) The composition of claim 21, wherein said expressible oligonucleotides are expressed as gVIII-fusion proteins on the surface of an E. coli filamentous bacteriophage. ### Claim 28 (depends on 21) An expressible oligonucleotide produced by the cloning system of claim 21. ### Claim 29 (depends on 21) A host cell containing the cloning system of claim 21. ### Claim 30 (depends on 24, 25) The cloning system of claim 24 or 25, wherein said amino acid is an amino acid selected from the group consisting of cysteine, glutamic acid, lysine, leucine and tyrosine. ### Claim 31 A population of vectors comprising a diverse population of oligonucleotides operationally linked to (i) expression elements, (ii) a suppressible stop codon and (iii) a nucleic acid encoding a coat protein so as to be expressed as a fusion protein with said coat protein of an E. coli filamentous bacteriophage in a suppressor host or as a secreted peptide in a non-suppressor host, said oligonucleotides having a desirable bias of random codon sequences, and more than one codon encoding an amino acid capable of forming a covalent bond. ### Claim 32 (depends on 31) A population of vectors of claim 31, wherein said amino acid is an amino acid selected from the group consisting of cysteine, glutamic acid, lysine, leucine and tyrosine. ### Claim 33 (depends on 32) A host cell containing the population of vectors of claim 32. ### Claim 34 (depends on 29, 33) A method of isolating a soluble peptide having a desirable bias of predetermined covalent constraints, comprising growing said host cell of claim 29 or 33 under suitable conditions favoring expression of said peptide, and affinity isolating said peptide so produced. ### Claim 35 A method of constructing a diverse population of vectors containing combined first and second oligonucleotide precursor populations, wherein each or either precursor oligonucleotides has a desirable bias of random codon sequences, and which express said combined oligonucleotides which encode random peptides having a desirable bias of predetermined covalent constraints, wherein at least one of said peptides exhibits constrained secondary structure, comprising the steps of: (a) operationally linking sequences from a diverse population of first precursor oligonucleotides having a desirable bias of random codon sequences to a first E. coli filamentous bacteriophage vector; (b) operationally linking sequences from a diverse population of second precursor oligonucleotides having a desirable bias of random codon sequences to a second E. coli filamentous bacteriophage vectors, wherein said first or second, or first and second precursor oligonucleotides have at least one codon capable of forming a covalent bond; and (c) combining the vector products of steps (a) and (b) under conditions where said populations of first and second precursor oligonucleotides are joined together into a population of combined vectors which express said random peptides as a fusion with a coat protein or as a secreted peptide. ### Claim 36 (depends on 35) The method of claim 35, wherein said amino acid is an amino acid selected from the group consisting of cysteine, glutamic acid, lysine, leucine and tyrosine. ### Claim 37 (depends on 35) The method of claim 35, wherein steps (a) through (d) are repeated two or more times.